|
1
|
Emkey GR and Epstein S: Secondary
osteoporosis: Pathophysiology & diagnosis. Best Pract Res Clin
Endocrinol Metab. 28:911–935. 2014. View Article : Google Scholar
|
|
2
|
Shiraishi A, Higashi S, Masaki T, Saito M,
Ito M, Ikeda S and Nakamura T: A comparison of alfacalcidol and
menatetrenone for the treatment of bone loss in an ovariectomized
rat model of osteoporosis. Calcif Tissue Int. 71:69–79. 2002.
View Article : Google Scholar
|
|
3
|
Eriksson F, Mattsson P and Larsson S: The
effect of augmentation with resorbable or conventional bone cement
on the holding strength for femoral neck fracture devices. J Orthop
Trauma. 16:302–310. 2002. View Article : Google Scholar
|
|
4
|
Huang Y, Bo Y, Wu X, Wang Q, Qin F, Zhao L
and Xiong Z: An intergated serum and urinary metabonomic research
based on UPLC-MS and therapeutic effects of Gushudan on
prednisolone-induced osteoporosis rats. J Chromatogr B Analyt
Technol Biomed Life Sci. 1027:119–130. 2016. View Article : Google Scholar
|
|
5
|
Siu WS, Qin L, Cheung WH and Leung KS: A
study of trabecular bones in ovariectomized goats with
micro-computed tomography and peripheral quantitative computed
tomography. Bone. 35:21–26. 2004. View Article : Google Scholar
|
|
6
|
Lill CA, Fluegel AK and Schneider E: Sheep
model for fracture treatment in osteoporotic bone: A pilot study
about different induction regimens. J Oorthop Trauma. 14:559–566.
2000. View Article : Google Scholar
|
|
7
|
Wang Z and Zhao J: Research progress in
osteoporotic models. Chin J Osteoporos. 2012.
|
|
8
|
Silverman SL and Lane NE:
Glucocorticoid-induced osteoporosis. Curr Osteoporos Rep. 7:23–26.
2009. View Article : Google Scholar
|
|
9
|
Dai W, Jiang L, Lay YA, Chen H, Jin G,
Zhang H, Kot A, Ritchie RO, Lane NE and Yao W: Prevention of
glucocorticoid induced bone changes with beta-ecdysone. Bone.
74:48–57. 2015. View Article : Google Scholar :
|
|
10
|
Xia X, Kar R, Gluhak-Heinrich J, Yao W,
Lane NE, Bonewald LF, Biswas SK, Lo WK and Jiang JX:
Glucocorticoid-induced autophagy in osteocytes. J Bone Miner Res.
25:2479–2488. 2010. View
Article : Google Scholar :
|
|
11
|
Canalis E, Mazziotti G, Giustina A and
Bilezikian JP: Glucocorticoid-induced osteoporosis: Pathophysiology
and therapy. Osteoporos Int. 18:1319–1328. 2007. View Article : Google Scholar
|
|
12
|
Rauch A, Seitz S, Baschant U, Schilling
AF, Illing A, Stride B, Kirilov M, Mandic V, Takacz A,
Schmidt-Ullrich R, et al: Glucocorticoids suppress bone formation
by attenuating osteoblast differentiation via the monomeric
glucocorticoid receptor. Cell Metab. 11:517–531. 2010. View Article : Google Scholar
|
|
13
|
Schober A, Parlato R, Huber K, Kinscherf
R, Hartleben B, Huber TB, Schütz G and Unsicker K: Cell loss and
autophagy in the extra-adrenal chromaffin organ of Zuckerkandl are
regulated by glucocorticoid signalling. J Neuroendocrinol.
25:34–47. 2013. View Article : Google Scholar
|
|
14
|
Chang JK, Li CJ, Liao HJ, Wang CK, Wang GJ
and Ho ML: Anti-inflammatory drugs suppress proliferation and
induce apoptosis through altering expressions of cell cycle
regulators and pro-apoptotic factors in cultured human osteoblasts.
Toxicology. 258:148–156. 2009. View Article : Google Scholar
|
|
15
|
Jia J, Yao W, Guan M, Dai W, Shahnazari M,
Kar R, Bonewald L, Jiang JX and Lane NE: Glucocorticoid dose
determines osteocyte cell fate. FASEB J. 25:3366–3376. 2011.
View Article : Google Scholar :
|
|
16
|
Gao L, Cai G and Shi X: Beta-ecdysterone
induces osteogenic differentiation in mouse mesenchymal stem cells
and relieves osteoporosis. Biol Pharm Bull. 31:2245–2249. 2008.
View Article : Google Scholar
|
|
17
|
Omanakuttan A, Bose C, Pandurangan N,
Kumar GB, Banerji A and Nair BG: Nitric Oxide and ERK mediates
regulation of cellular processes by Ecdysterone. Exp Cell Res.
346:167–175. 2016. View Article : Google Scholar
|
|
18
|
Zhang X, Xu X, Xu T and Qin S:
β-Ecdysterone suppresses interleukin-1beta-induced apoptosis and
inflammation in rat chondrocytes via inhibition of NF-kappaB
signaling pathway. Drug Dev Res. 75:195–201. 2014.
|
|
19
|
Zou Y, Wang R, Guo H and Dong M:
Phytoestrogen β-ecdysterone protects PC12 cells against
MPP+−induced neurotoxicity in vitro: Involvement of
PI3K-Nrf2-regulated pathway. Toxicol Sci. 147:28–38. 2015.
View Article : Google Scholar
|
|
20
|
Pan Z, Niu Y, Liang Y, Zhang X and Dong M:
β-Ecdysterone protects SH-SY5Y cells against
6-hydroxydopamine-induced apoptosis via mitochondria-dependent
mechanism: Involvement of p38(MAPK)-p53 signaling pathway. Neurotox
Res. 30:453–466. 2016. View Article : Google Scholar
|
|
21
|
Ominsky MS, Li X, Asuncion FJ, Barrero M,
Warmington KS, Dwyer D, Stolina M, Geng Z, Grisanti M, Tan HL, et
al: RANKL inhibition with osteoprotegerin increases bone strength
by improving cortical and trabecular bone architecture in
ovariectomized rats. J Bone Miner Res. 23:672–682. 2008. View Article : Google Scholar
|
|
22
|
Houlihan DD, Mabuchi Y, Morikawa S, Niibe
K, Araki D, Suzuki S, Okano H and Matsuzaki Y: Isolation of mouse
mesenchymal stem cells on the basis of expression of Sca-1 and
PDGFR-α. Nat Protoc. 7:2103–2111. 2012. View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Walsh CM and Edinger AL: The complex
interplay between autophagy, apoptosis, and necrotic signals
promotes T-cell homeostasis. Immunol Rev. 236:95–109. 2010.
View Article : Google Scholar :
|
|
25
|
Lee HK, Lund JM, Ramanathan B, Mizushima N
and Iwasaki A: Autophagy-dependent viral recognition by
plasmacytoid dendritic cells. Science. 315:1398–1401. 2007.
View Article : Google Scholar
|
|
26
|
Yue Z, Jin S, Yang C, Levine AJ and Heintz
N: Beclin 1, an autophagy gene essential for early embryonic
development, is a haploinsufficient tumor suppressor. Proc Natl
Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar :
|
|
27
|
Lawrence T: The nuclear factor NF-kappaB
pathway in inflammation. Cold Spring Harb Perspect Biol.
1:a0016512009. View Article : Google Scholar :
|
|
28
|
McDonnell P, McHugh PE and O'Mahoney D:
Vertebral osteoporosis and trabecular bone quality. Ann Biomed Eng.
35:170–189. 2007. View Article : Google Scholar
|
|
29
|
Roux JP, Wegrzyn J, Boutroy S, Bouxsein
ML, Hans D and Chapurlat R: The predictive value of trabecular bone
score (TBS) on whole lumbar vertebrae mechanics: An ex vivo study.
Osteoporos Int. 24:2455–2460. 2013. View Article : Google Scholar
|
|
30
|
Chen P, Miller PD, Recker R, Resch H, Rana
A, Pavo I and Sipos AA: Increases in BMD correlate with
improvements in bone microarchitecture with teriparatide treatment
in postmenopausal women with osteoporosis. J Bone Miner Res.
22:1173–1180. 2007. View Article : Google Scholar
|
|
31
|
Jehle S, Hulter HN and Krapf R: Effect of
potassium citrate on bone density, microarchitecture, and fracture
risk in healthy older adults without osteoporosis: A randomized
controlled trial. J Clin Endocrinol Metab. 98:207–217. 2013.
View Article : Google Scholar
|
|
32
|
Styrkarsdottir U, Cazier JB, Kong A,
Rolfsson O, Larsen H, Bjarnadottir E, Johannsdottir VD,
Sigurdardottir MS, Bagger Y, Christiansen C, et al: Linkage of
osteoporosis to chromosome 20p12 and association to BMP2. PLoS
Biol. 1:E692003. View Article : Google Scholar :
|
|
33
|
Mundy C, Gannon M and Popoff SN:
Connective tissue growth factor (CTGF/CCN2) negatively regulates
BMP-2 induced osteoblast differentiation and signaling. J Cell
Physiol. 229:672–681. 2014. View Article : Google Scholar :
|
|
34
|
Yamaguchi Y, Sakai E, Sakamoto H, Fumimoto
R, Fukuma Y, Nishishita K, Okamoto K and Tsukuba T: Inhibitory
effects of tert-butylhydroquinone on osteoclast differentiation via
up-regulation of heme oxygenase-1 and down-regulation of HMGB1
release and NFATc1 expression. J Appl Toxicol. 34:49–56. 2014.
View Article : Google Scholar
|
|
35
|
Bustamante M, Nogués X, Agueda L, Jurado
S, Wesselius A, Cáceres E, Carreras R, Ciria M, Mellibovsky L,
Balcells S, et al: Promoter 2 −1025 T/C polymorphism in the RUNX2
gene is associated with femoral neck bmd in Spanish postmenopausal
women. Calcif Tissue Int. 81:327–332. 2007. View Article : Google Scholar
|
|
36
|
Zhu FB, Wang JY, Zhang YL, Quan RF, Yue
ZS, Zeng LR, Zheng WJ, Hou Q, Yan SG and Hu YG: Curculigoside
regulates proliferation, differentiation, and pro-inflammatory
cytokines levels in dexamethasone-induced rat calvarial
osteoblasts. Int J Clin Exp Med. 8:12337–12346. 2015.
|
|
37
|
Wang FS, Ko JY, Weng LH, Yeh DW, Ke HJ and
Wu SL: Inhibition of glycogen synthase kinase-3beta attenuates
glucocorticoid-induced bone loss. Life Sci. 85:685–692. 2009.
View Article : Google Scholar
|
|
38
|
Weinstein RS, Jilka RL, Parfitt AM and
Manolagas SC: Inhibition of osteoblastogenesis and promotion of
apoptosis of osteoblasts and osteocytes by glucocorticoids.
Potential mechanisms of their deleterious effects on bone. J Clin
Invest. 102:274–282. 1998. View
Article : Google Scholar :
|
|
39
|
Liu W, Dai N, Wang Y, Xu C, Zhao H, Xia P,
Gu J, Liu X, Bian J, Yuan Y, et al: Role of autophagy in
cadmium-induced apoptosis of primary rat osteoblasts. Sci Rep.
6:204042016. View Article : Google Scholar :
|
|
40
|
Piemontese M, Onal M, Xiong J, Wang Y,
Almeida M, Thostenson JD, Weinstein RS, Manolagas SC and O'Brien
CA: Suppression of autophagy in osteocytes does not modify the
adverse effects of glucocorticoids on cortical bone. Bone.
75:18–26. 2015. View Article : Google Scholar :
|
|
41
|
Wells GA, Cranney A, Peterson J, Boucher
M, Shea B, Robinson V, Coyle D and Tugwell P: Alendronate for the
primary and secondary prevention of osteoporotic fractures in
postmenopausal women. Cochrane Database Syst Rev.
1:CD0011552008.
|
